RIMA M SALIBA to Fusion Proteins, bcr-abl
This is a "connection" page, showing publications RIMA M SALIBA has written about Fusion Proteins, bcr-abl.
Connection Strength
0.039
-
Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia. Bone Marrow Transplant. 2004 May; 33(10):1005-9.
Score: 0.039